(Q33756474)

29 July 2017

title

Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF (English)

1 reference

29 July 2017

Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1136/JNNP.34.3.219

4 June 2023

1 reference

parkinsonian syndrome

1 reference

1 reference

https://api.crossref.org/works/10.1136/JNNP.34.3.219

4 June 2023

author name string

R. B. Godwin-Austen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5571307

4 June 2023

language of work or name

English

0 references

publication date

1 June 1971

1 reference

full work available at URL

29 July 2017

https://europepmc.org/articles/PMC1083454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5571307

https://europepmc.org/articles/PMC1083454?pdf=render

4 June 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5571307

https://syndication.highwire.org/content/doi/10.1136/jnnp.34.3.219

4 June 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1136/JNNP.34.3.219

Journal of Neurology, Neurosurgery and Psychiatry

4 June 2023

published in

1 reference

29 July 2017

volume

34

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

219-223

1 reference

5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Treatment of Parkinsonism With Levodopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using th

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Treatment of Parkinsonism with Laevo-Dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

L-dopa in idiopathic parkinsonism.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Modification of Parkinsonism--chronic treatment with L-dopa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from Parkinsonism

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1083454

Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia

30 October 2018

1 reference

12 December 2020

Effects of L-dopa in Parkinson's disease.

1 reference

12 December 2020

L-dopa and cerebrospinal fluid homovanillic acid in parkinsonism

1 reference

12 December 2020

Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid

1 reference

12 December 2020

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

1 reference

12 December 2020

[The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat]

1 reference

12 December 2020

Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients

1 reference

12 December 2020

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference